Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis

Aims: The effect of the angiotensin receptor–neprilysin inhibitor (ARNI) sacubitril-valsartan in patients with heart failure with preserved ejection fraction (HFpEF) remains unclear, and data on ARNI treatment in peritoneal dialysis (PD) patients are lacking. The present study was designed to assess...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Med (Lausanne)
Autores principales: Fu, Sha, Xu, Zhenjian, Lin, Baojuan, Chen, Junzhe, Huang, Qiuyan, Xu, Yanchun, Xu, Anping, Chen, Yangxin, Tang, Ying
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255468/
https://ncbi.nlm.nih.gov/pubmed/34235161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.657067
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares